Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.
Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.
This report contains market size and forecasts of Vascular Closure Devices (VCDS) in global, including the following market information:
Global Vascular Closure Devices (VCDS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vascular Closure Devices (VCDS) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Vascular Closure Devices (VCDS) companies in 2021 (%)
The global Vascular Closure Devices (VCDS) market was valued at 809.7 million in 2021 and is projected to reach US$ 1202.4 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5F-6F Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vascular Closure Devices (VCDS) include Abbott Laboratories, Abbott, Cardinal Health and Morrris Innovative, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vascular Closure Devices (VCDS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vascular Closure Devices (VCDS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Closure Devices (VCDS) Market Segment Percentages, by Type, 2021 (%)
5F-6F
5F-21F
Global Vascular Closure Devices (VCDS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Closure Devices (VCDS) Market Segment Percentages, by Application, 2021 (%)
Angiography Surgery
Interventional Procedures
Global Vascular Closure Devices (VCDS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Closure Devices (VCDS) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vascular Closure Devices (VCDS) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vascular Closure Devices (VCDS) revenues share in global market, 2021 (%)
Key companies Vascular Closure Devices (VCDS) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Vascular Closure Devices (VCDS) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Abbott
Cardinal Health
Morrris Innovative